Independent and cutting-edge analysis on Turkey and its neighborhood
Turkey is at the vanguard of a global trend of implementing universal health coverage. Building on that leadership position, Prime Minister Erdoğan has set a goal for Turkey to become a global leader in the delivery of health services over the next decade. A key element of developing the health care market in Turkey is expanding the country’s biopharmaceutical sector. For Turkey to meet its health care objectives, it needs to maintain a public policy environment that ensures adequate resources for health care and fosters innovation and investment in the biopharmaceutical sector. Too often, the government’s short-term cost containment polices have conflicted with its aspirations for ensuring Turkish citizens have access to needed innovative therapies and growing a biopharmaceutical sector.
 
 
CONTRIBUTOR
Rod Hunter
Rod Hunter
From the Desk of the Editor TPQ’s Summer 2018 issue marks the 11th annual edition that we are publishing with the support of NATO’s Public Diplomacy Division. This long-standing partnership has helped TPQ in its efforts to feature nuanced and diverse opinions on the security policy challenges facing Turkey, the region, and the transatlantic community. Over the years, we have had the privilege of bringing the...
STAY CONNECTED
SIGN UP FOR NEWSLETTER
TWEETS
FACEBOOK
PARTNERS